Tuesday, October 09, 2018 3:03:04 PM
That's a good point - IMO applies more to bond funds, preferred stocks, and utilities, which you mentioned, all of which move inversely with interest rates - but one of my two bond funds (PDI) hedges against increases in rates with currency and interest rate swaps, they won't be hurt at all. One of my hybrid mREITs (NRZ) benefits from rising rates too, because prepayments of mortgages go down, and new loans have higher rates. What worries me more than interest rates is inflation and the affect of new tariffs on earnings - that can drive both the div and pps down, a double whammy. Amazon doesn't pay a div, but they just announced they're raising their minimum wage from $7.50 to $15, and that's a trend that's not going to stop, employers are desperate for certain types of workers, and it's going to hit earnings hard. I wouldn't own Walmart for that reason plus effects of tariffs on the goods they sell, which are mostly made in China.
Another thing to be wary of is stocks or funds that use Return of Capital (ROC) to pay distributions - that's usually a red flag, although in expensive asset companies like shippers depreciation is what classifies the divs as ROC - but it's called "Good ROC", simply a tax accounting thing***. Even worse is something that uses ROC, but it's actually Return of Principal - you're just getting your own money back, or in the cases of some ETFs/CEFs you're getting new investor's money as new units are created and sold. Same thing goes for companies that borrow money or do secondary offerings to pay divs - stay far, far away - gets really complicated when it comes to REITs because of the way they accounting - tracking book value is critical to know whether secondaries are acretive or dilutive.
*** Good ROC can be great for a taxable account - it's not a qualified dividend, so it doesn't get taxed, it just lowers your cost basis, so you get to choose when to take the tax hit if/when you sell - then it's taxed at cap gains rates. If you die, whomever gets the stock has a new basis (not yours), which is whatever the pps of the stock is when transferred, so they could sell and pay no taxes on the transaction because they've made zero profits as far as the IRS is concerned.
Another thing to be wary of is stocks or funds that use Return of Capital (ROC) to pay distributions - that's usually a red flag, although in expensive asset companies like shippers depreciation is what classifies the divs as ROC - but it's called "Good ROC", simply a tax accounting thing***. Even worse is something that uses ROC, but it's actually Return of Principal - you're just getting your own money back, or in the cases of some ETFs/CEFs you're getting new investor's money as new units are created and sold. Same thing goes for companies that borrow money or do secondary offerings to pay divs - stay far, far away - gets really complicated when it comes to REITs because of the way they accounting - tracking book value is critical to know whether secondaries are acretive or dilutive.
*** Good ROC can be great for a taxable account - it's not a qualified dividend, so it doesn't get taxed, it just lowers your cost basis, so you get to choose when to take the tax hit if/when you sell - then it's taxed at cap gains rates. If you die, whomever gets the stock has a new basis (not yours), which is whatever the pps of the stock is when transferred, so they could sell and pay no taxes on the transaction because they've made zero profits as far as the IRS is concerned.
The Thought Police: To censor and protect. Craig Bruce
Recent AMRN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
- Amarin Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/25/2026 12:00:00 PM
- This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 25, 2026 • GlobeNewswire Inc. • 02/11/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:06 AM
